Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -4.90% | 58.57 | 0.0% | $906.01m | |
| AMGN | Amgen, Inc. | 1.22% | 258.24 | 1.3% | $750.82m | |
| GILD | Gilead Sciences, Inc. | 0.38% | 76.35 | 1.0% | $724.94m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.18% | 622.45 | 2.5% | $659.43m | |
| NVAX | Novavax, Inc. | 2.43% | 81.64 | 102.0% | $580.82m | |
| BIIB | Biogen, Inc. | 0.13% | 265.12 | 1.6% | $559.05m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.68% | 291.10 | 1.9% | $527.74m | |
| ILMN | Illumina, Inc. | 1.24% | 373.10 | 3.5% | $308.62m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.08% | 112.30 | 2.0% | $228.46m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.75% | 126.78 | 4.3% | $214.78m | |
| SGEN | Seattle Genetics, Inc. | 0.90% | 169.03 | 6.1% | $202.30m | |
| SRNE | Sorrento Therapeutics, Inc. | -1.15% | 6.85 | 1.8% | $184.40m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.77% | 162.75 | 13.9% | $167.23m | |
| INCY | Incyte Corp. | 3.72% | 106.47 | 2.5% | $163.35m | |
| IMMU | Immunomedics, Inc. | 1.71% | 37.54 | 11.0% | $159.56m |
Company Profile
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ.